Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Heart Failure Prevention (HOMAGE)
NCT02556450Phase 2Completed
- Sponsor
- ACS Biomarker
- Start
- Jan 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of spironolactone in heart failure (HF), sponsored by ACS Biomarker. Started Jan 2016; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02556450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556450.